Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Imris Inc T.IM

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies
Alternate Symbol(s):  IMRS

IMRIS Inc designs, manufactures and markets the VISIUS Surgical TheatreTM, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment.
Price: $1.45 | Change: +$0.15 | %Change: +11.54%
Volume: 219,125 | Day High/Low: 1.49/1.34 | 52 Week High/Low: 3.20/0.215
View modes: 
0 stars

Nice action today...

Could be a nice lead in to an earnings announcement this week followed by earnings next week. Should be an interesting couple of weeks.  rate and reply
0 stars

RE:RE:RE:RE:Hello everyone

I hope you pick some up when is was under a $1.05  rate and reply
0 stars

RE:RE:RE:RE:Hello everyone

Hey I'm happy lol. There is nothing wrong with this one for its cheap. The Morningstar Quantitative Research has IM at undervalued and has a price of $1.5. You want Canadian companies that are dealing...read more
0 stars

RE:RE:RE:Hello everyone

@ hallgg not happy  rate and reply
0 stars

RE:RE:Hello everyone

@ happy,  Any other cheap stocks that you can recommend? Appreciate any leads or feedback.  rate and reply
0 stars

RE:Hello everyone

You never know with the FDA for i's have to be dotted and the t's cross. My guess will be late March.  rate and reply
0 stars

Hello everyone

Thank you guys for the feedback.  Very low activity here for input on Imris.  What do people feel about this one?  Think it will take off?  Think FDA will approve this week?  Think earnings report...read more
5 stars

RE:Where is Imris going.

They do not have any profit from their revenue is the street view. I still loaded up at $.25. Lots changed since then. Heavy insider buying. Deerfield Management Co finances them which to me if you...read more
0 stars

RE:Where is Imris going.

I don't know...This seems to have a pattern of running up into Feb and then pulling way down for a year. It has done it the last two years....that being said, it did not have the Seimans alliance...read more
0 stars

Where is Imris going.

As a reference piece would suggest you check out Imris under the Yahoo website under ticker "imrs". Many posts here show reference to the latest news on Imris . This company is still under the radar...read more
0 stars

RE:RE:No delisting from Nasdaq

Where is this stock going?  Anyone has a take on this?  All its competitors are well above Imris.  rate and reply
0 stars

RE:No delisting from Nasdaq

So the bar is set  rate and reply
0 stars

No delisting from Nasdaq

Congratulations for clearing this issue . Ten straight working days with stock price over a $1.00 US  This could free up some institutions that may have had buying restrictions on stocks under a...read more
0 stars

RE:Any feedback...

Buy it cheap. Only one bottom line :)  rate and reply
0 stars

Any feedback...

technicals still look good but reversal could happen. Any feedback...  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Heck...

It did show some strength today throughout...  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:RE:Heck...

tomorrow will tell.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:Heck...

in on yesterday's dip. :) cheers, dave.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:Heck...

Yes I think your right,  It needs to rest a bit like it did at the dollar mark.   If runs go to far to fast it just comes crashing down again.   Should make for a good entry or add point then climb...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:Heck...

it will pick up again soon.  rate and reply